"IN-PART can be used to test whether there is interest in a particular technology and help to determine geographical filing decisions by using the map to see who has looked at your technology. By marketing during the provisional application stage, it may be easier to close a technology before expending …

“Through due diligence, investors and pharma companies take a closer look at their potential partner, the asset, and the deal itself to validate claims and evaluate risks. With many millions of dollars riding on the success of licensing and acquisition activities, a deal gone wrong can mean significant debt and …